期刊文献+

卡介苗诱导膀胱癌细胞cyclinD1、Fas表达的实验研究 被引量:1

Bacillus Calmette-Guerin inhibition the growth of bladder cancer cells through regulation of cyclinD_1 and Fas
下载PDF
导出
摘要 目的观察卡介苗(BCG)对体外培养膀胱癌细胞生长情况及相关基因(cyclinD1、Fas)表达的影响,并探讨其可能的作用机制。方法MTT法检测不同浓度BCG(0.15、0.3、0.6、1.2mg/mL)对人膀胱癌BIU-87细胞生长的影响。流式细胞术(FCM)检测BCG处理后膀胱癌细胞周期分布的变化及对膀胱癌细胞凋亡的影响;逆转录-聚合酶链反应(RT-PCR)检测BCG作用BIU-87细胞后cyclinD1、FasmRNA表达的变化。结果BCG体外能明显抑制BIU-87细胞的生长,且抑制作用呈明显的剂量、时间依赖性(P<0.01)。流式细胞术检测示处理后膀胱癌细胞阻滞于G0~G1期,RT-PCR结果示BCG处理能显著诱导FasmRNA的表达和显著抑制cyclinD1mRNA的表达(P<0.05)。结论TSA可通过诱导细胞凋亡和使细胞阻滞于G1期而发挥体外抗膀胱癌作用,其作用机制可能涉及相关基因(cyclinD1、Fas)表达的调控。 Objective To investigate the influence of Bacillus Calmette-Guerin (BCG) on the growth of human bladder cancer cells and the expression of related genes, and to explore the involved mechanism. Methods A human bladder cancer cell line, BIU-87, was treated with different concentrations(0.15, 0.3, 0.6, 1.2 mg/mL) of BCG. After treatment, cell growth was measured by MTT assay. Cell apoptosis changes and the cell cycle distribution were examined by flow cytometry (FCM).mRNA expression of cyclinD1 and Fas was assessed by reverse transcription-polymerase chain reaction. Results Bacillus Calmette-Guerin significantly inhibited the proliferation of bladder cancer cell in a time- and dose-dependent manner. Flow cytometry showed that the cells were blocked at G0-G1 phase and cell apoptosis increased. It was showed by reverse transcription-polymerase chain reaction that the Fas mRNA level increased while the cyclinD1 mRNA level dropped after BCG treatment. Oonclusion The results indicate that BCG is able to inhibit bladder cancer cell growth in vitro by inducing cell apoptosis and cell cycle arrest,which might be related to the expression of cyclinD1 and Fas.
出处 《现代泌尿外科杂志》 CAS 2010年第2期99-102,共4页 Journal of Modern Urology
基金 湖北省科技攻关计划项目(2007AA301B15-4)
关键词 膀胱癌 BCG细胞周期 细胞凋亡 CYCLIND1 FAS bladder cancer Bacillus Calmette-Guerin cell cycle apoptosis cyclinD1 Fas
  • 相关文献

参考文献10

  • 1BABJUK M, OOSTERLINCK W, SYLVESTER RJ, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder[J]. Eur Urol,2008,54(2):303-314.
  • 2SYLVESTER RJ, VAN DER MEIJDEN APM, OOSTER- LINCK W,et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials[J]. Eur Urol,2006,49(3) :466-477.
  • 3Hall MC, Chang SS, Dalbagni G, et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis) : 2007 update[J]. J Urol,2007,178(6) :2314-2330.
  • 4HERR HW, MORALES A. History of bacillus balmette-guerin and bladder cancer: an immunotherapy success story [J]. J Urol, 2008,179(1) : 53-56.
  • 5MARTINEZ-PINEIRO JA, MARTINEZ-PINEIRO L, SOLSONA E,et al. Has a 3- fold decreased dose of bacillus Calmette- Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial[J]. J Urol, 2005, 174 (4Pt1) :1242-1247.
  • 6OJEA A, NOGUEIRA JL, SOLSONA E, et al. A multieentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27mg) versus very low-dosc bacillus Calmette-Guerin (13. 5 mg) versus mitomycin C[J]. Eur Urol,2007,52(5) :1398-1406.
  • 7EDUARDO S,CATSLINA L,RUTH C, et al. Cathepsin B is involved in the apoptosis intrinsic pathway induced by Bacillus Calmette-Guerin in transitional cancer cell lines[J], Int J Mol Med, 2007,20(6) :823-828.
  • 8FISHEL ML, NEWELL DR, GRIFFIN RJ, et al. Effect of cell cycle inhibition on Cisplatin- induced cytotoxicity[J]. J Pharmacol Exp Ther, 2005,312 ( 1 ) : 206-213.
  • 9MCKNIGHT JJ, GRAY SB, O'KANE HF,et al. Apoptosis and chemotherapy for bladder cancer[J]. J Urol,2005,173 (3) :683-690.
  • 10FU M, WANG C, LI Z,et al. CyclinDl:normal and abnormal functions[J]. Endocrinology,2004, 145(8) :5439-5447.

同被引文献11

  • 1杨永长,黄文芳,卢贤瑜.他汀类药物抗肿瘤研究进展[J].国际检验医学杂志,2006,27(11):1031-1032. 被引量:8
  • 2Ikeda N,Toida I,Iwasaki A. Surface antigen expression on bladder tumor cell induced by bacillus Calmette-Guerin(BCG):A role of BCG-internalization into tumor cell[J].International Journal of Urology,2002,(01):29-35.
  • 3Grange JM,Stanford JL,Stanford CA. Vaccination strategies to reduce the risk of leukaemia and melanoma[J].Journal of the Royal Society of Medicine,2003,(08):389-392.
  • 4Uyl-de Groot CA,Vermorken JB,Hanna MG Jr. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer:a prospective study of medical and economic benefits[J].Vaccine,2005,(17-18):2379-2387.doi:10.1016/j.vaccine.2005.01.015.
  • 5Chen F,Zhang G,Iwamoto Y. BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking[J].BMC Urology,2005.
  • 6Zhang G,Chen F,Cao Y. Bacillus Calmette-Guérin induces p21 expression in human transitional carcinoma cell lines via an immediate early,p53 independent pathway[J].Urologic Oncology,2007,(03):221-227.
  • 7Gangwar R,Mittal RD. Association of selected variants in genes involved in cell cycle and apoptosis with bladder cancer risk in North Indian population[J].Dna and Cell Biology,2010,(07):349-356.
  • 8Bartek J,Lukas J. Pathways governing G1/S transition and their response to DNA damage[J].FEBS Letters,2001,(03):117-122.doi:10.1016/S0014-5793(01)02114-7.
  • 9Campanini F,Santucci MA,Brusa G. Expression of P21(WAF1/CIP1/SID1) cyclin-dependent kinase inhibitor in hematopoietic progenitor cells[J].Gene,2001,(04):173-180.
  • 10Méndez-Samperio P,Pérez A,Rivera L. Mycobacterium bovis Bacillus Calmette-Guérin (BCG)-induced activation of PI3K/Akt and NF-kB signaling pathways regulates expression of CXCL10 in epithelial cells[J].Cellular Immunology,2009,(1-2):12-18.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部